PlumX Metrics
Embed PlumX Metrics

Hematopoietic stem cell transplantation for systemic sclerosis with rapid improvement in skin scores: Is neoangiogenesis occurring?

Bone Marrow Transplantation, ISSN: 0268-3369, Vol: 32, Issue: S1, Page: S65-S67
2003
  • 17
    Citations
  • 0
    Usage
  • 23
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

Systemic sclerosis (SSc) is presumed to be an immune-mediated vasculopathy of unknown etiology. SSc is unresponsive to most immune-modulating therapies except for intravenous cyclophosphamide, which is reported to demonstrate some benefit. We, therefore, dose-escalated cyclophosphamide to 200 mg/kg and added rabbit ATG 7.5 mg/kg along with infusion of unselected hematopoietic stem cells to minimize the cytopenic interval. Engraftment occurred rapidly (day 8) with minimal unexpected toxicity, no infections, and unexpectedly rapid improvement in the modified Rodnan Skin Score. © 2003 Nature Publishing Group.

Bibliographic Details

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know